Skip to main content

Federal Judge May Include Smith & Nephew Hip Replacement Lawsuits with Hip Resurfacing MDL

Federal Judge May Include Smith & Nephew Hip Replacement Lawsuits with Hip Resurfacing MDL

Federal Judge May Include Smith & Nephew Hip Replacement Lawsuits with Hip Resurfacing MDL

Introduction

Federally-filed Smith & Nephew Birmingham Hip Replacement litigation is witnessing a steady growth in size with additional cases being filed by plaintiffs. As of April, there were more than 250 cases filed as a part of this litigation. Allegations include that the metal-on-metal hip resurfacing and replacement designs are defective and prone to fail, often requiring revision surgery to have them removed and replaced. The U.S. JPML decided to consolidate these cases in Maryland under Judge Catherine C. Blake in May 2017.

In a case management order (PDF) released by Judge Blake on May 3, both the parties agreed to include all the component related complaints in the Hip resurfacing system litigation, even though the component was used as part of a total hip replacement. As per the order, the hip replacement lawsuits will proceed on a separate track from the claims involving hip resurfacing procedures, which would be identified by the court periodically.

Hip replacement lawsuits continue to be filed under a related hip litigation involving Stryker Hip Lawsuits, centralized before U.S. District Judge Indira Talwani under MDL No. 2768 – in re: Stryker LFIT V40 Femoral Head Products Liability Litigation.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!